Heart transplantation in adults with end-stage congenital heart disease

2012 ◽  
Vol 8 (2) ◽  
pp. 329-342 ◽  
Author(s):  
Luke J Burchill ◽  
Heather J Ross
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Heart Transplantation ◽  
Congenital Heart ◽  
End Stage

Support/Transplantation

ESC CardioMed ◽  
2018 ◽  
pp. 788-790
Author(s):  
Michael Burch ◽  
Dilveer Panesar
Keyword(s):  
Heart Failure ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Heart Transplantation ◽  
Congenital Heart ◽  
Therapeutic Option ◽  
Blood Transfusions ◽  
End Stage

Heart transplantation is the only realistic therapeutic option for children with end-stage heart disease. Unlike in adults, ischaemic heart failure is rare and most paediatric transplant referrals are for cardiomyopathy and the rest for congenital heart disease. Patients with congenital heart disease pose difficulties in terms of their anatomy and the chronicity of the illness, often having had multiple surgeries and blood transfusions prior to transplantation.

scholarly journals Clinical use of percutaneous mechanical circulatory assistance in a patient with end-stage right-sided heart failure and massive tricuspid insufficiency due to congenital heart disease: first-in-the-world case report

2021 ◽  
Vol 5 (8) ◽  
Author(s):  
Mario García Gómez ◽  
Aitor Uribarri ◽  
José Alberto San Román Calvar ◽  
Alexander Stepanenko
Keyword(s):  
Heart Failure ◽  
Congenital Heart Disease ◽  
Heart Disease ◽  
Right Ventricle ◽  
Heart Transplantation ◽  
Right Ventricular ◽  
Congenital Heart ◽  
Ebstein’S Anomaly ◽  
Exclusion Criteria ◽  
End Stage

Abstract Background Due to improvement in the management of patients with congenital heart disease (CHD), the likelihood of their survival to adulthood is increasing. A relevant population suffers end-stage right ventricular failure (RVF) in their 3rd–4th decade of life. Hence, heart transplantation is still gold standard of treatment of end-stage heart failure, mechanical circulatory assistance has become a valuable tool in the bridging to heart transplant or definitive therapy. Use of implantable short-term or long-term devices is reported by others. However, within this clinical context, presence of significant tricuspid regurgitation (TR) or CHD is used as exclusion criteria for insertion of a percutaneous right ventricular circulatory support. Case summary We described a 36-year-old patient diagnosed with Ebstein's anomaly and severe TR who is admitted to hospital due to RVF refractory to standard medical treatment. After case presentation to the heart team, an Impella RP device insertion was scheduled, in spite of the presence of TR or CHD after evaluation of pulmonary valve competency and 3D reconstruction with virtual device implantation. During support, the patient improved clinically and haemodynamically. Due to device displacement to the right ventricle, it was bedside explanted after 30 days of support. After mechanical unloading during 30 days patients’ right ventricle recovered partially, permitting patient to improve his functional class. Discussion Although TR and CHD are exclusion criteria for the implantation of the Impella RP device, we report clinical experience in patient with Ebstein's anomaly and severe TR supported with percutaneous device as bridge to heart transplantation during 30 days.

Heart transplantation in adults with congenital heart disease; experience with 15 patients

2005 ◽  
Vol 53 (S 3) ◽  
Author(s):  
O Coskun ◽  
T Coskun ◽  
N Reiss ◽  
U Schulz ◽  
A Parsa ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Heart Transplantation ◽  
Congenital Heart ◽  
Disease Experience

scholarly journals DONOR CHARACTERISTICS AND RECIPIENT OUTCOMES AFTER HEART TRANSPLANTATION IN ADULT CONGENITAL HEART DISEASE

2021 ◽  
Vol 77 (18) ◽  
pp. 639
Author(s):  
Geoffrey D. Huntley ◽  
David Danford ◽  
Jonathan Menachem ◽  
Shelby Kutty ◽  
Ari Cedars
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Heart Transplantation ◽  
Congenital Heart ◽  
Adult Congenital Heart Disease ◽  
Adult Congenital ◽  
Donor Characteristics

Comparison of inhospital outcomes of pediatric heart transplantation between single ventricle congenital heart disease and cardiomyopathy

2019 ◽  
Vol 23 (6) ◽  
Author(s):  
Tamara T. Bradford ◽  
Joshua A. Daily ◽  
Sean M. Lang ◽  
Jeffrey M. Gossett ◽  
Xinyu Tang ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Heart Transplantation ◽  
Congenital Heart ◽  
Single Ventricle ◽  
Pediatric Heart Transplantation

Mitochondrial respiratory abnormalities in patients with end-stage congenital heart disease

2004 ◽  
Vol 23 (1) ◽  
pp. 72-79 ◽  
Author(s):  
Seema Mital ◽  
Kit E Loke ◽  
Jonathan M Chen ◽  
Ralph S Mosca ◽  
Jan M Quaegebeur ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
End Stage ◽  
Mitochondrial Respiratory

scholarly journals Regression of Advanced Liver Fibrosis After Heart Transplantation in a Patient With Prior Fontan Surgery for Complex Congenital Heart Disease

2018 ◽  
Vol 11 (11) ◽  
Author(s):  
Judith Bouchardy ◽  
Philippe Meyer ◽  
Patrick Yerly ◽  
Coralie Blanche ◽  
Roger Hullin ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Liver Fibrosis ◽  
Heart Transplantation ◽  
Congenital Heart ◽  
Complex Congenital Heart Disease ◽  
Advanced Liver Fibrosis ◽  
Fontan Surgery
Sign in / Sign up

Export Citation Format

Share Document